In 2023, the Parkinson's disease mortality rate for men in the U.S. stood at 17.6 deaths per hundred thousand. The forecasted data from 2024 to 2028 indicates an annual increase of approximately one unit per year, reflecting a steady year-on-year growth of approximately 5.4% over this period. Notably, the compound annual growth rate (CAGR) over the five-year period is expected to align with this trend.

Future trends to watch for:

Demographic shifts, such as the aging population, may accelerate the increase in mortality rates.
Advancements in medical treatments and early interventions might mitigate growth.
Potential impacts of healthcare policy changes on Parkinson's disease management.